NCT03701113

Brief Summary

The process of bone remodeling exhibits pronounced diurnal pattern that is important for bone health. A balanced rate of bone resorption is required to maintain bone health, a balance that can be disturbed during the life-cycle to effect net rate of formation (as occurs during growth and development to adulthood) or net resorption (as occurs, for example, during the menopause). Bone turnover is a nutritionally modulated process and the investigators believe a milk-based protein supplement (MBPS) can modulate beneficially the rate of bone resorption over the time period when bone remodeling is most active i.e. late evening/overnight. In this novel approach to the timing of nutrient ingestion, the proposed nutrient intervention seeks to modify (reduce) the rate of bone resorption and promote the rate of bone formation to the benefit of bone health in this at risk population..

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 9, 2018

Completed
13 days until next milestone

Study Start

First participant enrolled

October 22, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2019

Completed
Last Updated

January 29, 2025

Status Verified

January 1, 2025

Enrollment Period

9 months

First QC Date

September 28, 2018

Last Update Submit

January 28, 2025

Conditions

Keywords

OsteoporosisPostmenopausalBone Turnover MarkersDairy Products

Outcome Measures

Primary Outcomes (1)

  • Aerial Bone Mineral Density (BMD)

    Site specific (hip and lumbar) BMD measured by Dual Energy X-ray Absorptiometry (DXA)

    Change from Baseline BMD at 24 weeks

Secondary Outcomes (2)

  • Bone Resorption

    Change from Baseline CTX, NTX and DPD at 24 weeks

  • Bone Formation

    Change from Baseline P1NP at 24 weeks

Study Arms (2)

Milk-based protein matrix (MBPM)

ACTIVE COMPARATOR

Intervention: Dietary Supplement : Test Product Intervention: Diagnostic Test : Aerial Bone Mineral Density (BMD) Intervention: Diagnostic Test : Bone Turnover Composition of Test Product - 25g of milk-based proteins + 1000mg dairy-based calcium fortified with 40ug Vit D flavoured and textured supplied food grade and product tested by Dairygold Co-operative Society, Mitchelstown, Ireland.

Dietary Supplement: Milk-based protein matrix (MBPM)

CONTROL

OTHER

Intervention: Habitual dietary behaviour Intervention: Diagnostic Test : Aerial Bone Mineral Density (BMD) Intervention: Diagnostic Test : Bone Turnover

Dietary Supplement: Habitual dietary behaviour

Interventions

Ingestion of the Test Product at 10:00 pm, post-absorptive of the evening meal, each day for the 24 week period of intervention

Milk-based protein matrix (MBPM)
Habitual dietary behaviourDIETARY_SUPPLEMENT

Subjects to maintain habitual dietary behaviour for the 24 week intervention

CONTROL

Eligibility Criteria

Age50 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Post-menopausal women aged 50-70y. Assessed by site-specific BMD to be osteopenic. Assessed by clinical screen to be otherwise healthy and free from other illness or current medication likely to influence the study outcome.

You may not qualify if:

  • Intolerance to dairy-based food products

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Limerick

Limerick, V94 T9PX, Ireland

Location

Related Links

MeSH Terms

Conditions

Osteoporosis, PostmenopausalOsteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Philip M Jakeman, PhD

    University of Limerick

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: A block randomised, controlled study among healthy, post-menopausal women with osteopenia receiving a milk-based protein supplement (MBPS) in the evening, or not (CONTROL), for a period of 24 weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2018

First Posted

October 9, 2018

Study Start

October 22, 2018

Primary Completion

July 30, 2019

Study Completion

July 30, 2019

Last Updated

January 29, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Study Protocol (2018_04_05_EHS)Access

Locations